Description

5-Pyrimidinecarboxamide, n-(8-Benzyl-3-β-Nortropanyl)-4-Ethoxy-2-Et Hyl- is a specialized heterocyclic organic compound that serves as a critical intermediate in advanced pharmaceutical synthesis. Its complex molecular architecture, featuring a pyrimidine core and a nortropane-derived moiety, makes it a valuable building block for research and development in medicinal chemistry. This high-purity intermediate is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of novel active pharmaceutical ingredients (APIs) and complex bioactive molecules.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of complex drug candidates, particularly those targeting neurological and receptor-based pathways.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Synthesis: Serves as a building block for creating other high-value, nitrogen-containing heterocyclic compounds.
• Biochemical Research: Potential use as a ligand or probe in biochemical assays studying specific enzyme or receptor interactions.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and scale-up of complex organic molecules.
• Academic Research: Utilized in university and institutional labs for methodological development in organic synthesis and chemical biology.

Basic Information

Product Name	5-Pyrimidinecarboxamide, n-(8-Benzyl-3-β-Nortropanyl)-4-Ethoxy-2-Et Hyl-
CAS No.	84923-07-9
Molecular Formula	C25H31N5O2
Molecular Weight	433.55 g/mol
Synonyms	N-(8-Benzyl-3β-nortropanyl)-4-ethoxy-2-ethyl-5-pyrimidinecarboxamide; 84923-07-9; 4-Ethoxy-2-ethyl-N-(8-phenylmethyl-3β-nortropan-3-yl)-5-pyrimidinecarboxamide; 5-Pyrimidinecarboxamide, N-(8-benzyl-3β-nortropanyl)-4-ethoxy-2-ethyl-; 2-Ethyl-4-ethoxy-N-(8-phenylmethyl-3β-nortropan-3-yl)pyrimidine-5-carboxamide
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We operate under a cGMP-compliant quality management system, and specifications can be aligned with client requirements for early-phase clinical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.